PERCEPTIVE ADVISORS LLC 13D and 13G filings for Cerevel Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-10-17 4:35 pm Purchase | 2023-10-16 | 13D | Cerevel Therapeutics Holdings, Inc. CERE | PERCEPTIVE ADVISORS LLC | 10,965,193 6.200% | 876,808![]() (+8.69%) | Filing |
2023-04-25 1:04 pm Unchanged | 2023-04-25 | 13D | Cerevel Therapeutics Holdings, Inc. CERE | PERCEPTIVE ADVISORS LLC | 10,088,385 6.400% | 0 (Unchanged) | Filing |
2023-04-21 5:23 pm Purchase | 2023-04-11 | 13D | Cerevel Therapeutics Holdings, Inc. CERE | PERCEPTIVE ADVISORS LLC | 10,088,385 6.400% | 10,088,385![]() (New Position) | Filing |